Fig. 1From: Incidence and predictors of major adverse drug events among drug-resistant tuberculosis patients on second-line anti-tuberculosis treatment in Amhara regional state public hospitals; Ethiopia: a retrospective cohort studyFlow chart showing a selection of DR-TB patients on second line anti-TB drugs in Amhara Regional State Public Hospitals from September 2010 to December 2017Back to article page